l carnitine tmao nature medicine 2013 koeth Revisiting the Role of in Heart Disease Through the Lens of the Gut Microbiota Gut Microbiota-Derived TMAO: A Causal
Gut Microbiota Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease? A Multi omic Association Study of Trimethylamine N Oxide ScienceDirect Butyrobetaine is a pro atherogenic intermediate in gut microbial metabolism of L carnitine to TMAO PMC Trimethylamine N Oxide and Related Gut Microbe Derived Metabolites and Incident Heart Failure Development in Community Based Populations Circulation: Heart Failure
Pay in 4 interest-free payments of $5.12 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



